cystatin-based compounds (Neobiotics)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecystatin-based compounds (Neobiotics)
Drug Alias Nameantibacterial/antiviral agents (Neobiotics AB)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOsteoclasts inhibitors
TargetsUpdating
Therapy Area/IndicationsOsteoporosisVirus DiseasesBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeobiotics AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeobiotics AB
Active IndicationsN/A
Inactive IndicationsOsteoporosisVirus DiseasesBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A